Urticaria

BOSTON — Acupuncture and other traditional Chinese medicine techniques may be helpful for allergic conditions, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

The FDA has accepted the resubmission of the supplemental biologics license application for Dupixent to treat chronic spontaneous urticaria in adults and children, Regeneron Pharmaceutical and Sanofi announced in a press release.

Patients with chronic spontaneous urticaria experienced a marked improvement with Dupixent treatment, according to phase 3 trial results released by Regeneron.

Omalizumab is effective and safe for the treatment of chronic urticaria, demonstrating high discontinuation due to well-controlled disease, according to a study.

Children experiencing egg-induced anaphylaxis may be seeing certain symptoms that differentiate them from other food-induced anaphylaxis, according to a study published in Annals of Allergy, Asthma and Immunology.

CLEVELAND — For patients with chronic spontaneous urticaria, lab testing can help to phenotype disease and guide treatment, according to James Fernandez, MD, PhD, an allergy and immunology specialist at the Cleveland Clinic.

This episode digs into the pathophysiology of urticaria vasculitis from anti-C1q to the story of bradykinin.

The first patient has been dosed in Jasper Therapeutic’s phase 1b/2a SPOTLIGHT clinical trial of subcutaneous briquilimab for the treatment of chronic inducible urticaria, the company announced in a press release.

WASHINGTON — Urticaria treatment guidelines in the United States include more options than the World Allergy Organization’s guidelines, according to a poster presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.